Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 308

The DOI matches its Crossref record.

The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change

Henderson, Rebecca, Orsenigo, Luigi, Pisano, Gary P.·1999·Sources of Industrial Leadership

Abstract

Introduction The last 25 years have seen a revolution in the biological sciences that has had several dramatic effects on the global pharmaceutical industry. These effects raise a number of fascinating questions about patterns of industrial evolution and about the interaction of scientific, organizational, and institutional changes. Although a cursory analysis might suggest that the revolution in molecular biology can be interpreted simply as a classic “Schumpeterian” event, in which the early days of the industry were characterized by high rates of entry and incumbents were gradually supplanted by a new breed of innovators, it has several features that make it quite distinctive from the “traditional” model. First, whereas the traditional model is derived largely from the study of radical shifts in engineering knowledge (Abernathy and Utterback, 1978; Tushman and Anderson, 1986), the revolution in molecular biology represented a shift in the scientific knowledge base of an industry. Second, despite the sweeping nature of the molecular revolution, incumbent pharmaceuticals companies have not been swept away by new entrants. Third, and relatedly, the relationships between incumbents and entrants has entailed not only competition, but also cooperation and the establishment of complex interactions between firms. Finally, and perhaps most importantly, the revolution did not create a monolithic new paradigm of technical development, but instead created two quite distinct trajectories of development that have only recently been combined: the use of biotechnology as a tool for the production of proteins whose therapeutic properties were already well understood, and the use of biotechnology as a tool in the search for entirely new therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/cbo9781139175128.007

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 308

Metadata

Authors
Henderson, R., Orsenigo, L., & Pisano, G. P.
Venue
Sources of Industrial Leadership
Published
1999-10-13
Pages
267-311
OpenAlex
W19747457
Cited by
308
References
0
FWCI
30.46
Type
book chapter
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change. https://app.cochat.ai/papers/10.1017/cbo9781139175128.007
The paper
Henderson, R., Orsenigo, L., & Pisano, G. P. (1999). The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change. Sources of Industrial Leadership. https://doi.org/10.1017/cbo9781139175128.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.